about
Adipokines, metabolic syndrome and rheumatic diseasesCirculating naive and memory CD4+ T cells and metabolic syndrome in patients with systemic lupus erythematosus: data from a primarily Mestizo population.Smoking and Its Association With Morbidity in Systemic Lupus Erythematosus Evaluated by the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index: Preliminary Data and Systematic Review.Metabolic syndrome is not only a risk factor for cardiovascular diseases in systemic lupus erythematosus but is also associated with cumulative organ damage: a cross-sectional analysis of 311 patients.Risk of non-alcoholic fatty liver disease in patients with psoriasis: a systematic review and meta-analysis.Attribution of cause of end-stage renal disease among patients with systemic lupus erythematosus: the Georgia Lupus RegistryImpact of heart rate variability, a marker for cardiac health, on lupus disease activity.Metabolic syndrome in lupus patients in northeast of Iran, and their lifestyle habits.Diagnostic morphology: biophysical indicators for iron-driven inflammatory diseases.Key advances in the clinical approach to ANCA-associated vasculitis.Systemic lupus erythematosus diagnosis and management.Impact of Therapy on Metabolic Syndrome in Young Adult Premenopausal Female Lupus Patients: Beneficial Effect of Antimalarials.Metabolic syndrome in Iranian patients with systemic lupus erythematosus and its determinants.Revisiting an unsolved problem - impact of SLICC criteria on the risk of metabolic syndrome.Impact of Diabetes Mellitus on the Risk of End-Stage Renal Disease in Patients with Systemic Lupus Erythematosus.Systemic Lupus Erythematosus in Primary Care: An Update and Practical Messages for the General Practitioner.
P2860
Q26865268-8049F4B8-555D-4AC5-9069-FE0402EA3353Q30870861-5830BE93-0A33-45A0-A103-BFB21385C486Q30993000-35EA7817-BC7F-4D82-9ED7-5824E0836BB4Q33425745-4DD3AEA3-8C70-4CA2-8451-40131ED896D6Q35444953-34B7F8DC-FBEB-41BC-B7E9-28F5F831F023Q36517240-692C3558-E71E-47A8-847F-E2ED99648373Q37230849-B93C546B-244F-4116-A7C4-DCC0B58B4A12Q37335690-A7E8CEE0-42A9-4F52-9138-8B03FFFC9FECQ38203153-DB76C128-B986-4E55-A382-79F43F6B004CQ38224803-EE439237-8873-40CF-8C79-B74D01B3818AQ39053129-0AC17364-0A9F-483F-AA40-E940815FF5A1Q41127869-00EA2722-027E-45DE-8B38-362BB745D938Q47179163-0DC9DB83-DC44-4221-AE6A-6CC94B7FAF8FQ53124596-BF3D2A68-07E9-4BC0-854F-4EBB9067782FQ53694839-BAB901BD-EE47-4B6B-A25A-2E3134592EE5Q55282858-AFB3639C-898B-4337-A2F8-882787F72612
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
SLE and metabolic syndrome.
@en
type
label
SLE and metabolic syndrome.
@en
prefLabel
SLE and metabolic syndrome.
@en
P2860
P356
P1433
P1476
SLE and metabolic syndrome.
@en
P2093
P2860
P304
P356
10.1177/0961203313502570
P50
P577
2013-10-01T00:00:00Z